Possis Medical
This article was originally published in The Gray Sheet
Executive Summary
Recent private placement financing expansion increases to $7 mil. funds raised to expand marketing of the AngioJet thrombectomy system for coronary arteries following FDA approval in March. The Minneapolis firm had initially raised $6 mil. ("The Gray Sheet" May 17, In Brief) before raising an additional $1 mil. from an another institutional investor